Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|May 10, 2017
Involvement and comfort of gynecologic oncologists in the treatment of pediatric, adolescent, and young adult patients with gynecologic malignanciesIra Winer, Divya Patel, Vanessa Dalton, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|September 13, 2020
Prognostic value of changes in neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and lymphocyte-to-monocyte ratio (LMR) for patients with cervical cancer undergoing definitive chemoradiotherapy (dCRT)Hamilton Trinh, Stephen Paul Dzul, Jalal Hyder, et al.Cancer Medicine|February 15, 2019
Serum folate receptor α (sFR) in ovarian cancer diagnosis and surveillanceBatoul Farran, Samet Albayrak, Judith Abrams, et al.Investigational New Drugs|February 19, 2024
A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinomaKathryn E Beckermann, Amita Patnaik, Ira Winer, et al.Journal of Cancer Science & Therapy|January 29, 2016
Comparative Analysis of Differentially Expressed miRNAs and their Downstream mRNAs in Ovarian Cancer and its Associated EndometriosisRichard Licheng Wu, Shadan Ali, Sudeshna Bandyopadhyay, et al.Cancer Research|January 20, 2007
Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformationYing Feng, Guido T Bommer, Yali Zhai, et al.Cancer Research|October 21, 2010
F3-targeted cisplatin-hydrogel nanoparticles as an effective therapeutic that targets both murine and human ovarian tumor endothelial cells in vivoIra Winer, Shouyan Wang, Yong-Eun Koo Lee, et al.Urogynecology (Philadelphia, Pa.)|January 27, 2026
Safety and Feasibility of Concomitant Urogynecologic and Gynecologic Oncology Surgical ProceduresKyle Wohlrab, Katina Robison, David D Rahn, et al.Cancer Immunology, Immunotherapy : CII|March 30, 2024
Ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients with advanced solid tumoursManish R Patel, Melissa Johnson, Ira Winer, et al.Gynecologic Oncology|January 28, 2026
Safety and feasibility of concomitant urogynecologic and gynecologic oncology surgical proceduresKyle Wohlrab, Katina Robison, David D Rahn, et al.Pageof 4